Macroporous silica nanoparticles for delivering Bcl2-function converting peptide to treat multidrug resistant-cancer

Weixia Xu1, Pengjin Ge1, Boning Niu1

  • 1School of Pharmaceutical Sciences, and Fujian Provincial Key Laboratory of Innovative Drug Target Research, Xiamen University, Xiang'an South Road, Xiamen, Fujian 361102, China.

Insights

Researchers developed macroporous silica nanoparticles to deliver a peptide that converts cancer-protective Bcl-2 into a killer. This novel drug delivery platform effectively treats multidrug-resistant cancer cells by enhancing peptide delivery and efficacy.

Area of Science:

  • Biomaterials Science
  • Nanotechnology
  • Cancer Biology

Background:

  • B cell lymphoma gene 2 (Bcl-2) promotes cancer cell survival and chemoresistance.
  • A peptide from orphan nuclear receptor Nur77 can reverse Bcl-2's function, turning it into a cancer cell killer.
  • Efficient delivery of therapeutic peptides to cancer cells remains a significant challenge, especially with traditional small-pore nanoparticles.

Purpose of the Study:

  • To engineer a novel delivery platform for a Bcl-2-converting peptide.
  • To overcome limitations of small-pore mesoporous silica nanoparticles for peptide delivery.
  • To investigate the role of pore size and surface functionality in nanoparticle-mediated peptide delivery for treating multidrug-resistant cancer.

Main Methods:

  • Fabrication of macroporous silica nanoparticles (MSNs) with tunable pore sizes and surface functionalities.
  • Modification of MSNs with thiol and amine groups to enhance peptide loading and cellular uptake.
  • Evaluation of peptide encapsulation efficiency and intracellular delivery into MCF7/DOX cancer cells.
  • Assessment of peptide-induced apoptosis via mitochondrial targeting and Bcl-2 BH3 domain exposure.

Main Results:

  • Macroporous silica nanoparticles demonstrated high peptide-loading efficiency (>40%), particularly with thiol modification.
  • Surface-functionalized MSNs facilitated peptide penetration into cancer cells and mitochondria.
  • The peptide successfully bound to Bcl-2, exposing the BH3 domain and inducing apoptosis.
  • Amine-modified MSNs showed a pronounced effect on peptide-induced apoptosis compared to other modifications.

Conclusions:

  • Engineered macroporous silica nanoparticles provide an effective platform for delivering Bcl-2-converting peptides.
  • Tuning nanoparticle pore size and surface functionality is crucial for efficient delivery of biomacromolecules.
  • This approach offers a promising strategy for treating multidrug-resistant cancers with elevated Bcl-2 levels.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Peptide Bonds02:43

Peptide Bonds

A peptide bond covalently attaches amino acids through a dehydration reaction. One amino acid's carboxyl group and another amino acid's amino group combine, releasing a water molecule. The resulting bond is the peptide bond. The products that such linkages form are peptides. As more amino acids join this growing chain, the resulting chain is a polypeptide. Each polypeptide has a free amino group at one end. This end has the N-terminal, or the amino-terminal, and the other end has a free...
83.4K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
2.6K
Resistivity01:22

Resistivity

When a voltage is applied to a conductor, an electrical field is generated, and charges in the conductor feel the force due to the electrical field. The current density that results depends on the electrical field and the properties of the material. In some materials, including metals at a given temperature, the current density is approximately proportional to the electrical field. In these cases, the current density can be modeled as:
4.6K
Resistance01:19

Resistance

When a current moves through any conductor, the conductor causes some level of difficulty for the current to flow. The measure of that difficulty is known as the resistance of the material and is represented by R. Every material has its own resistance. In the case of conductors, heat is emitted whenever a current passes through them. Resistance depends on the resistivity of the material. Resistivity is a characteristic of the material used to fabricate electrical components, whereas the...
6.0K
Silica Gel Column Chromatography: Overview01:10

Silica Gel Column Chromatography: Overview

Silica gel column chromatography is a technique for separating compounds using a column packed with silica gel as the stationary phase. This method relies on differences in the polarity of compounds. Based on their polarities, compounds move between the stationary phase (silica gel) and the mobile phase (the solvent), forming discrete bands in the column.
Polar components tend to bind strongly to the silica gel, causing them to move slowly through the column. In contrast, nonpolar compounds...
3.7K